Attention Nader bashers; Nader: Dr. Paul Madd
Post# of 148186
(Total Views: 537)
Posted On: 01/24/2021 4:32:27 PM
Attention Nader bashers;
Nader: Dr. Paul Maddon, inventor , was on the call at my request. I had asked him to come on the call. He said no, no, no, no. There is no GvHD [graft versus host indication] for leronlimab. This was four and a half, five years ago.
replyto=6027918#ixzz6kVFySuJt
Thankfully, NP did not listen to the inventor! He went ahead on his own based on *some* blockage of chemokines, and had the fantastic preclinical result in GvHD.
So, all the early HIV related material from CYDY falsely claimed that PRO140 did not block chemokines CCL3, CCL4, and CCL5 from binding to CCR5 , and that's why there was no toxicity (compared to maraviroc). That was clearly false information from Progenics, as blocking chemokines is how LL works for cancer and Covid and all these autoimmune diseases. Progenics had a potential gold mine but didn't realize it!
Read More: https://investorshangout.com/post/view?id=602...z6kVEnvuKP
Nader: Dr. Paul Maddon, inventor , was on the call at my request. I had asked him to come on the call. He said no, no, no, no. There is no GvHD [graft versus host indication] for leronlimab. This was four and a half, five years ago.
replyto=6027918#ixzz6kVFySuJt
Thankfully, NP did not listen to the inventor! He went ahead on his own based on *some* blockage of chemokines, and had the fantastic preclinical result in GvHD.
So, all the early HIV related material from CYDY falsely claimed that PRO140 did not block chemokines CCL3, CCL4, and CCL5 from binding to CCR5 , and that's why there was no toxicity (compared to maraviroc). That was clearly false information from Progenics, as blocking chemokines is how LL works for cancer and Covid and all these autoimmune diseases. Progenics had a potential gold mine but didn't realize it!
Read More: https://investorshangout.com/post/view?id=602...z6kVEnvuKP
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼